A Randomized, Control Trial for Preinduction Cervical Ripening
NCT ID: NCT00393731
Last Updated: 2008-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
540 participants
INTERVENTIONAL
2004-01-31
2007-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cervical Ripening for Induction of Labor: Misoprostol Versus Oxytocin in Conjunction With Foley Balloon
NCT01139801
Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening
NCT04949633
Combined Agent Randomized Trial of Induction of Labor
NCT00504465
Outpatient Cervical Ripening
NCT04041687
Clinical Evaluation of Cervical Ripening in the Outpatient Setting
NCT04271722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol
oxytocin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* singleton gestation
* cephalic presentation
* 24 weeks gestational age
Exclusion Criteria
* malpresentation
* placenta previa or abruption
* clinically suspected or diagnosed intra amniotic infection
* genital HSV infection
* multiple gestation
* premature rupture of the membranes
* active labor
* maternal/fetal conditions that may preclude labor induction in the opinion of the investigators
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The University of Texas Health Science Center, Houston
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Lucas, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lyndon B. Johnson Hospital
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-MS-04-008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.